Tyra Biosciences, Inc. TYRA Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s operating cash flow?
- Tyra Biosciences, Inc. (TYRA) reported operating cash flow of -$32.57M in Q1 2026.
- How has Tyra Biosciences, Inc.'s operating cash flow changed year-over-year?
- Tyra Biosciences, Inc.'s operating cash flow decreased by 27.9% year-over-year, from -$25.46M to -$32.57M.
- What is the long-term trend for Tyra Biosciences, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Tyra Biosciences, Inc.'s operating cash flow has grown at a 41.5% compound annual growth rate (CAGR), from -$23.75M to -$95.14M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.